MEDICXI
Medicxi is an international investment firm focused on the life sciences sector. It was established in 2016 by the former Index Ventures life sciences team, who have been active for over 20 years and have significant experience in drug discovery and the development of therapeutics for unmet medical needs.
MEDICXI
Industry:
Biopharma Biotechnology Life Science Venture Capital
Founded:
2016-02-01
Status:
Active
Contact:
+44 20 7952 1788
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Google Universal Analytics
Similar Organizations
Benaruca
Benaruca is a life science investment firm.
Cavalry Ventures
Cavalry is a Berlin-based early-stage Venture Capital fund.
Emerging Technology Partners
Emerging Technology Partners is a life sciences focused investment firm.
Perwyn
Perwyn is an entrepreneurial, privately-funded investment firm.
Steadview Capital
Steadview is a tech-focused investment firm that invests in technology oriented businesses.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-29 | MiroBio | Medicxi investment in Series B - MiroBio | 80 M GBP |
| 2021-09-08 | Xenikos | Medicxi investment in Convertible Note - Xenikos | 40 M EUR |
| 2021-08-31 | Versanis Bio | Medicxi investment in Series A - Versanis Bio | 70 M USD |
| 2021-08-10 | Sydnexis | Medicxi investment in Series B - Sydnexis | 45 M USD |
| 2021-07-20 | Rivus Pharmaceuticals | Medicxi investment in Series A - Rivus Pharmaceuticals | 35 M USD |
| 2021-06-10 | Kurome Therapeutics | Medicxi investment in Series A - Kurome Therapeutics | 15 M USD |
| 2021-03-22 | Aura Biosciences | Medicxi investment in Venture Round - Aura Biosciences | 80 M USD |
| 2020-10-07 | Janpix | Medicxi investment in Series B - Janpix | 10 M USD |
| 2020-09-25 | Palladio Biosciences | Medicxi investment in Series B - Palladio Biosciences | 20 M USD |
| 2020-06-10 | Checkmate Pharmaceuticals | Medicxi investment in Series C - Checkmate Pharmaceuticals | 85 M USD |
More informations about "Medicxi"
Medicxi
Ottimo Pharma Emerges from Stealth with Backing from Medicxi and Management Team Led by David Epstein to Accelerate Development of a Novel PD1/VEGFR2 Bi-Functional AntibodySee details»
Who are the Medicxi founding team? | Medicxi
The four partners who led the Index Ventures life sciences practice are the founding partners of medicxi and will constitute its executive management team: Francesco De Rubertis, David …See details»
Medicxi - Crunchbase Investor Profile & Investments
Medicxi is an investment firm that focuses on the life sciences sector. It was established in 2016 by the former Index Ventures life sciences team, who have been active for over 20 years and have significant experience in drug …See details»
Medicxi - Investments, Portfolio & Company Exits - Crunchbase
Oct 28, 2024 · Medicxi's most notable exits include Vaxcyte, New Amsterdam Pharma, and ProfoundBio. Medicxi has made 48 investments. Their most recent investment was on Oct 28, …See details»
The Formation of Medicxi
Today we are thrilled to announce the formation of a new life sciences-dedicated venture firm, Medicxi (pronounced MEH-DEE-CHEE) (see here). Medicxi starts operations today as one of …See details»
Medicxi Ventures (formerly Index Ventures Life Sciences)
Feb 2, 2016 · Medicxi is based in London, Geneva and Jersey. The firm's mission is to invest across the full healthcare continuum. Medicxi was established by the former Index Ventures …See details»
European VC Medicxi raises $400M for ‘asset-centric’ biotech …
Jul 27, 2023 · European life sciences investment firm Medicxi on Thursday said it raised $400 million, becoming the latest biotech-focused venture firm to boost its capital reserves so far …See details»
Medicxi Announces $400m Medicxi IV - PR Newswire
Jul 27, 2023 · LONDON, GENEVA, ST HELIER, Jersey, July 27, 2023 /PRNewswire/ -- Medicxi, a leading European life sciences investment firm, today announces its $400 million Medicxi IV …See details»
Hello Medicxi - Index Ventures
Feb 2, 2016 · Today is an important day in my life as a founder of Index Ventures as it marks the birth of a new firm that springs from our own. As of today, Medicxi Ventures will carry forward all of the life science investment activity that has …See details»
Medicxi rakes in $400M for 4th life sciences fund - Fierce Biotech
Jul 27, 2023 · Medicxi has loaded up its fourth fund with $400 million, which the European life sciences firm will use to continue its mission of supporting “asset-focused” biotechs.See details»
Approach - Medicxi
Our mission is to bring novel therapies to patients in need. We do this by creating, investing and supporting biotech companies along the full drug development continuum, from discovery …See details»
10 biotechs become 1: Centessa launches with $250M to
Feb 16, 2021 · Created from a merger of 10 startups backed by U.K. life sciences investment firm Medicxi, Centessa Pharmaceuticals aims to build the infrastructure of a larger drugmaker …See details»
Medicxi primes its latest $400m biotech fund | pharmaphorum
Oct 25, 2024 · Anglo-Swiss life sciences investment company Medicxi has raised $400 million for its fourth fund, which will focus on supporting 'asset-centric' companies at all stages of drug …See details»
Medicxi founds biotech creation engine C21Med
Mar 20, 2018 · Medicxi has created an “ideas factory” to boost its capacity to turn early-stage science into pipelines of drug candidates and startups to develop them. The VC fund is setting …See details»
Michele Ollier - Co-Founder & Partner @ Medicxi - Crunchbase
Michele Ollier is the Co-Founder & Partner at Medicxi. Additionally, Michele Ollier has had 7 past jobs including Partner at Index Ventures.See details»
Medicxi Closes a New €400m Fund (Medicxi III) to Power the Next …
Jul 19, 2019 · €400m Medicxi III fund, closed in just six weeks, and brings the total funds raised by Medicxi in the last three years to over $1b; Medicxi III will invest across the full healthcare …See details»
Medicxi raises €400m as Europe warms up to biopharma
Jul 19, 2019 · Medicxi, one of Europe’s biggest life sciences investment companies, has secured a further €400m from investors in just six weeks as appetite for betting on often risky …See details»
Medicxi announces the closing of its first €200 million Secondary …
Sep 22, 2020 · The interests in six clinical and preclinical stage companies held by Index Ventures Life VI, a dedicated life sciences fund advised by Medicxi, were acquired by a newly …See details»
Responsible Investment Policy - Medicxi
This policy sets out Medicxi’s approach to incorporating environmental and social factors into the Medicxi investment process for all assets under management. It is designed to comply with the …See details»
MSF - Médecins Sans Frontières | Medical humanitarian organisation
Médecins Sans Frontières brings medical humanitarian assistance to victims of conflict, natural disasters, epidemics or healthcare exclusion. Learn about how, why, and where MSF teams ...See details»